Understanding the biological factors behind opioid addiction
Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction (ICAN)
This study is looking into the biological reasons behind opioid addiction by examining genetic and molecular information from people and animals, with the goal of helping us understand why some people are more likely to become addicted than others.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-11086850 on NIH RePORTER |
What this research studies
This research aims to uncover the biological drivers of opioid addiction by conducting extensive studies that integrate genetic and molecular data from both humans and animal models. The project will analyze large datasets to identify specific genes and networks that contribute to addiction, ultimately creating a national resource for further research. By combining insights from various omics technologies, the research seeks to address the complexities of opioid addiction and improve our understanding of individual differences in susceptibility to this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of opioid use or addiction, as well as those with genetic predispositions to addictive behaviors.
Not a fit: Patients who do not have any history of opioid use or addiction may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and treatment strategies for opioid addiction.
How similar studies have performed: Previous research has shown success in using integrated omics approaches to understand other addictive disorders, suggesting potential for similar breakthroughs in opioid addiction.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Johnson, Eric Otto — Research Triangle Institute
- Study coordinator: Johnson, Eric Otto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.